about
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The...
Read More
14.46
0.78
(5.70%)
3.1M
XNAS Volume
High volume+gain today
XNAS 30 Jul, 2025 4:08 PM (EDT)
Board Meeting
The next board meeting for uniQure N.V. is on 01 Aug 2025 for the purpose of uniQure NV Second Quarter Earnings Results for 2025
See details
Not Eligible
Expensive Valuation
Technically Neutral
uniQure N.V. Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..